SCHEMBL6442259

SCHEMBL6442259

CC[C@@H]1CC(=O)C[C@H]1CC

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.36
NOS1 P29475 2/20 0.36
NOS2 P35228 2/20 0.36
MAPK1 P28482 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12629173 1.00 NOS3 (0.36) NOS3NOS1NOS2MAPK1MEN1
SCHEMBL6437994 1.00 NOS3 (0.36) NOS3NOS1NOS2MAPK1MEN1
SCHEMBL9754958 1.00 NOS3 (0.36) NOS3NOS1NOS2MAPK1MEN1
SCHEMBL1934068 0.87 BRD4 (0.33) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL1934066 0.87 BRD4 (0.33) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL1933580 0.87 BRD4 (0.33) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL6440814 0.87 NOS1 (0.39) NOS3NOS1NOS2
SCHEMBL1933577 0.87 BRD4 (0.33) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL6438530 0.87 NOS1 (0.39) NOS3NOS1NOS2
SCHEMBL27873411 0.87 NOS3 (0.30) NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050215816-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids BLAKEMORE DAVID C 2005-09-29 US claimed
US-6872856-B2 Cyclic ketones, their preparation and their use in the synthesis of amino acids WARNER-LAMBERT COMPANY (US) 2005-03-29 US claimed
US-20030187296-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids WARNER-LAMBERT COMPANY 2003-10-02 US claimed
EP-1296921-A1 CYCLIC KETONES, THEIR PREPARATION AND THEIR USE IN THE SYNTHESIS OF AMINO ACIDS WARNER-LAMBERT COMPANY (US) 2003-04-02 EP claimed
WO-2002000584-A1 CYCLIC KETONES, THEIR PREPARATION AND THEIR USE IN THE SYNTHESIS OF AMINO ACIDS WARNER-LAMBERT COMPANY (US) 2002-01-03 WO claimed
US-20050215816-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids BLAKEMORE DAVID C 2005-09-29 US disclosed
US-6872856-B2 Cyclic ketones, their preparation and their use in the synthesis of amino acids WARNER-LAMBERT COMPANY (US) 2005-03-29 US disclosed
US-20030187296-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids WARNER-LAMBERT COMPANY 2003-10-02 US disclosed
EP-1296921-A1 CYCLIC KETONES, THEIR PREPARATION AND THEIR USE IN THE SYNTHESIS OF AMINO ACIDS WARNER-LAMBERT COMPANY (US) 2003-04-02 EP disclosed
WO-2002000584-A1 CYCLIC KETONES, THEIR PREPARATION AND THEIR USE IN THE SYNTHESIS OF AMINO ACIDS WARNER-LAMBERT COMPANY (US) 2002-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215816-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids BCAT1, BCAT2, AKR1C3 NOS3 1337/4885NOS1 1273/4885NOS2 2081/4885
US-20030187296-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids BCKDK, GABRR1, GAP43 NOS3 3325/4885NOS1 3579/4885NOS2 4224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.